President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, like depression, PTSD and addiction.
Delaware Public Media's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Trump's order is a milestone for proponents of using psychedelics as medicine
Headline from Delaware Public Media ·
Newest
The least-psychedelic president in history supports psychedelic research more than any of his predecessors
Trump signed an executive order to expedite research into the psychedelic ibogaine – a drug championed by podcaster Joe Rogan – so it can be used to treat...
President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs."
President Donald Trump signed an executive order Saturday accelerating reviews of psychedelic drugs for medical purposes, including mental health conditions.
President Trump's executive order aims to fast-track psychedelics for PTSD and depression treatment. Supporters and critics offer mixed reactions on safety and efficacy.
A new executive order could make it easier for researchers studying how psychedelic drugs such as psilocybin, LSD and ibogaine may be useful in medicine
President Trump has signed an executive order aimed at accelerating research and approval of psychedelics for treating mental health conditions, like depression, PTSD and addiction.
